Decoding the immune microenvironment of secondary chronic myelomonocytic leukemia due to DLBCL with CD19 CAR-T failure by single-cell RNA-seq
{{output}}
Background: Several studies have demonstrated the occurrence of secondary tumors as a rare but significant complication of chimeric antigen receptor T (CAR-T) cell therapy, underscoring the need for a detailed investigation. Give... ...
